Modulatory effect of environmental context and drug history on heroin-induced psychomotor activity and fos protein expression in the rat brain

Neuropsychopharmacology

Volumn 32, Issue 12, 2007, Pages 2611-2623

  Paolone, Giovanna ^a   Conversi, David ^a   Caprioli, Daniele ^a   Bianco, Paola Del ^a   Nencini, Paolo ^a   Cabib, Simona ^a,b   Badiani, Aldo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

Author keywords

Environment; Fos; Heroin; Sensitization

Indexed keywords

DIAMORPHINE; PROTEIN FOS;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; ENVIRONMENT; HEROIN DEPENDENCE; LOCOMOTION; MALE; NEOCORTEX; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOMOTOR ACTIVITY; RAT; STRIATE CORTEX;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DRUG ADMINISTRATION SCHEDULE; ENVIRONMENT; GENE EXPRESSION REGULATION; HEROIN; MALE; MOTOR ACTIVITY; NARCOTICS; ONCOGENE PROTEINS V-FOS; RATS; RATS, SPRAGUE-DAWLEY; REGRESSION ANALYSIS;

EID: 34247897758     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301388     Document Type: Article

References (78)

1. Antonilli L, Petecchia E, Caprioli D, Badiani A, Nencini P (2005). Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat. Psychopharmacology (Berlin) 182: 58-64.
2. Antonilli L, Semeraro F, Suriano C, Signore L, Nencini P (2003a). High levels of morphine-6-glucuronide in street heroin addicts. Psychopharmacology (Berlin) 170: 200-204.
3. Antonilli L, Suriano C, Paolone G, Badiani A, Nencini P (2003b). Repeated exposures to heroin and/or cadmium alter the rate of formation of morphine glucuronides in the rat. J Pharmacol Exp Ther 307: 651-660.
4. Badiani A, Anagnostaras SG, Robinson TE (1995a). The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment. Psychopharmacology (Berlin) 117: 443-452.
5. Badiani A, Browman KE, Robinson TE (1995b). Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res 674: 291-298.
6. Badiani A, Camp DM, Robinson TE (1997). Enduring enhancement of amphetamine sensitization by drug-associated environmental stimuli. J Pharmacol Exp Ther 282: 787-794.
7. Badiani A, Oates MM, Day HEW, Watson SJ, Akil H, Robinson TE (1998). Amphetamine-induced behavior, dopamine release and c-fos mRNA expression: modulation by environmental novelty. J Neurosci 18: 10579-10593.
8. Badiani A, Oates MM, Day HEW, Watson SJ, Akil H, Robinson TE (1999). Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav Brain Res 103: 203-209.
9. Badiani A, Oates MM, Robinson TE (2000). Modulation of morphine sensitization in the rat by contextual stimuli. Psychopharmacology (Berlin) 151: 273-282.
10. Badiani A, Robinson TE (2004). Drug-induced neurobehavioral plasticity: the role of environmental context. Behav Pharmacol 15: 327-339.
11. Berretta S, Parthasarathy HB, Graybiel AM (1997). Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J Neurosci 17: 4752-4763.
12. Bontempi B, Sharp FR (1997). Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area. J Neurosci 17: 8596-8612.
13. Browman KE, Badiani A, Robinson TE (1998a). Modulatory effect of environmental stimuli on the susceptibility to amphetamine sensitization: a dose-effect study in rats. J Pharmacol Exp Ther 287: 1007-1014.
14. Browman KE, Badiani A, Robinson TE (1998b). The influence of environment on the induction of sensitization to the psychomotor activating effects of intravenous cocaine in rats is dose-dependent. Psychopharmacology (Berlin) 137: 90-98.
15. Cadoni C, Solinas M, Di Chiara G (2000). Psychostimulant sensitization: differential changes in accumbal shell and core dopamine. Eur J Pharmacol 388: 69-76.
16. Conversi D, Orsini C, Cabib S (2004). Distinct patterns of Fos expression induced by systemic amphetamine in the striatal complex of C57BL/6JICo and DBA/2JICo inbred strains of mice. Brain Res 1025: 59-66.
17. Crombag HS, Badiani A, Robinson TE (1996). Signalled versus unsignalled intravenous amphetamine: large differences in the acute psychomotor response and sensitization. Brain Res 722: 227-231.
18. Curran EJ, Akil H, Watson SJ (1996). Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem Res 21: 1425-1435.
19. D'Este L, Scontrini A, Casini A, Pontieri FE, Renda TG (2002). Heroin sensitization as mapped by c-Fos immunoreactivity in the rat striatum. Brain Res 933: 144-149.
20. Day HEW, Badiani A, Uslaner JM, Oates MM, Vittoz NM, Robinson TE et al (2001). Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala. J Neurosci 21: 732-740.
21. De Vries TJ, Schoffelmeer AN, Binnekade R, Mulder AH, Vanderschuren LJ (1998). Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur J Neurosci 10: 3565-3571.
22. Devine DP, Leone P, Pocock D, Wise RA (1993). Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther 266: 1236-1246.
23. Everitt BJ, Wolf ME (2002). Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22: 3312-3320.
24. Fadda F, Argiolas A, Melis MR, Tissari AH, Onali PL, Gessa GL (1978). Stress-induced increase in 3, 4-dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in n. accumbens: reversal by diazepam. Life Sci 23: 2219-2224.
25. Ferguson SM, Norton CS, Watson SJ, Akil H, Robinson TE (2003). Amphetamine-evoked c-fos mRNA expression in the caudateputamen: the effects of DA and NMDA receptor antagonists vary as a function of neuronal phenotype and environmental context. J Neurochem 86: 33-44.
26. Ferguson SM, Robinson TE (2004). Amphetamine-evoked gene expression in striatopallidal neurons: regulation by corticostriatal afferents and the ERK/MAPK signaling cascade. J Neurochem 91: 337-348.
27. Ferguson SM, Thomas MJ, Robinson TE (2004). Morphine-induced c-fos mRNA expression in striatofugal circuits: modulation by dose, environmental context, and drug history. Neuropsychopharmacology 29: 1664-1674.
28. Fraioli S, Crombag HS, Badiani A, Robinson TE (1999). Susceptibility to amphetamine-induced locomotor sensitization is modulated by environmental stimuli. Neuropsychopharmacology 20: 533-541.
29. Fu L, Beckstead RM (1992). Cortical stimulation induces fos expression in striatal neurons. Neuroscience 46: 329-334.
30. Garcia MM, Anderson AT, Edwards R, Harlan RE (2003). Morphine induction of c-fos expression in the rat forebrain through glutamatergic mechanisms: role of non-N-methyl-D-aspartate receptors. Neuroscience 119: 787-794.
31. Gerfen CR (1992). The neostriatal mosaic: multiple levels of compartmental organization. J Neural Transm Suppl 36: 43-59.
32. Haemmig RB, Tschacher W (2001). Effects of high-dose heroin versus morphine in intravenous drug users: a randomised double-blind crossover study. J Psychoactive Drugs 33: 105-110.
33. Harlan RE, Garcia MM (1998). Drugs of abuse and immediate-early genes in the forebrain. Mol Neurobiol 16: 221-267.
34. Heimer L, Zahm DS, Alheid GF (1995). Basal ganglia. In: Paxinos G (ed). The Rat Nervous System, 2nd edn. Academic Press: San Diego. pp 689-704.
35. Hope BT, Simmons DE, Mitchell TB, Kreuter JD, Mattson BJ (2006). Cocaine-induced locomotor activity and Fos expression in nucleus accumbens are sensitized for 6 months after repeated cocaine administration outside the home cage. Eur J Neurosci 24: 867-875.
36. Hughes P, Dragunow M (1995). Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 47: 133-178.
37. Hutcheson DM, Parkinson JA, Robbins TW, Everitt BJ (2001). The effects of nucleus accumbens core and shell lesions on intravenous heroin self-administration and the acquisition of drug-seeking behaviour under a second-order schedule of heroin reinforcement. Psychopharmacology (Berlin) 153: 464-472.
38. Hyman SE, Malenka RC (2001). Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2: 695-703.
39. Jacobs EH, de Vries TJ, Smit AB, Schoffelmeer AN (2004). Gene transcripts selectively down-regulated in the shell of the nucleus accumbens long after heroin self-administration are up-regulated in the core independent of response contingency. FASEB J 18: 200-202.
40. Joel D, Weiner I (2000). The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96: 451-474.
41. Johnson SW, North RA (1992). Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12: 483-488.
42. Kalivas PW, Duffy P (1995). Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res 675: 325-328.
43. Kendall JM, Reeves BC, Latter VS, Nasal Diamorphine Trial Group (2001). Multicentre randomised controlled trial of nasal diamorphine for analgesia in children and teenagers with clinical fractures. BMJ 322: 261-265.
44. Levesque M, Bedard A, Cossette M, Parent A (2003). Novel aspects of the chemical anatomy of the striatum and its efferents projections. J Chem Neuroanat 26: 271-281.
45. Li Y, Kolb B, Robinson TE (2003). The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology 28: 1082-1085.
46. Liu J, Nickolenko J, Sharp FR (1994). Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 91: 8537-8541.
47. Marinelli M, Le Moal M, Piazza PV (1998). Sensitization to the motor effects of contingent infusions of heroin but not of kappa agonist RU 51599. Psychopharmacology (Berlin) 139: 281-285.
48. Matthews RT, German DC (1984). Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience 11: 617-625.
49. Mikkola JA, Honkanen A, Piepponen TP, Kiianmaa K, Ahtee L (2000). Effects of repeated morphine on cerebral dopamine release and metabolism in AA and ANA rats. Pharmacol Biochem Behav 67: 783-791.
50. Moleman P, Bruinvels J (1979). Morphine-induced striatal dopamine efflux depends on the activity of nigrostriatal dopamine neurones. Nature 281: 686-687.
51. Nestler EJ (2001). Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119-128.
52. Noguchi T, Yoshida Y, Chiba S (2001). Effects of psychological stress on monoamine systems in subregions of the frontal cortex and nucleus accumbens of the rat. Brain Res 916: 91-100.
53. Ostrander MM, Badiani A, Day HEW, Norton CS, Watson SJ, Akil H et al (2003). Environmental context and drug history modulate amphetamine-induced c-fos mRNA expression in the basal ganglia, central extended amygdala, and associated limbic forebrain. Neuroscience 120: 551-571.
54. Paolone G, Burdino R, Badiani A (2003). Dissociation in the modulatory effects of environmental novelty on the locomotor, analgesic, and eating response to acute and repeated morphine in the rat. Psychopharmacology (Berlin) 166: 146-155.
55. Papa M, Pellicano MP, Welzl H, Sadile AG (1993). Distributed changes in c-Fos and c-Jun immunoreactivity in the rat brain associated with arousal and habituation to novelty. Brain Res Bull 32: 509-515.
56. Pasternak GW (2001). Incomplete cross tolerance and multiple mu opioid peptide receptors. Trends Pharmacol Sci 22: 67-70.
57. Paxinos G, Watson C (1997). The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego.
58. Pontieri FE, Calo L, Di Grezia R, Orzi F, Passarelli F (1997). Functional correlates of heroin sensitization in the rat brain. Eur J Pharmacol 335: 133-137.
59. Rady JJ, Roerig SC, Fujimoto JM (1991). Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. J Pharmacol Exp Ther 256: 448-457.
60. Riedel A, Hartig W, Seeger G, Gartner U, Brauer K, Arendt T (2002). Principles of rat subcortical forebrain organization: a study using histological techniques and multiple fluorescence labeling. J Chem Neuroanat 23: 75-104.
61. Robinson TE, Becker JB (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396: 157-198.
62. Robinson TE, Berridge KC (2000). The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95(Suppl 2): S91-S117.
63. Schuller AG, King MA, Zhang J, Bolan E, Pan YX, Morgan DJ et al (1999). Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci 2: 151-156.
64. Sgambato V, Abo V, Rogard M, Besson MJ, Deniau JM (1997). Effect of electrical stimulation of the cerebral cortex on the expression of the Fos protein in the basal ganglia. Neuroscience 81: 93-112.
65. Shalev U, Grimm JW, Shaham Y (2002). Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54: 1-42.
66. Spyraki C, Fibiger HC, Phillips AG (1983). Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology (Berlin) 79: 278-283.
67. Stewart J, Badiani A (1993). Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4: 289-312.
68. Stewart J, Vezina P (1988). A comparison of the effects of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior. Brain Res 457: 287-294.
69. Tschacher W, Haemmig R, Jacobshagen N (2003). Time series modeling of heroin and morphine drug action. Psychopharmacology (Berlin) 165: 188-193.
70. Ujike H, Takaki M, Kodama M, Kuroda S (2002). Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann NY Acad Sci 965: 55-67.
71. Uslaner J, Badiani A, Day HEW, Watson SJ, Akil H, Robinson TE (2001a). Environmental Context modulates the ability of cocaine and amphetamine to induce c-fos mRNA expression in the neocortex, caudate nucleus, and nucleus accumbens. Brain Res 920: 106-116.
72. Uslaner J, Badiani A, Norton CS, Day HEW, Watson SJ, Akil H et al (2001b). Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci 13: 1977-1983.
73. Vaccarino FJ, Bloom FE, Koob GF (1985). Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology (Berlin) 86: 37-42.
74. Vaccarino FJ, Corrigall WA (1987). Effects of opiate antagonist treatment into either the periaqueductal grey or nucleus accumbens on heroin-induced locomotor activation. Brain Res Bull 19: 545-549.
75. Vanderschuren LJ, Kalivas PW (2000). Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berlin) 151: 99-120.
76. Wan XS, Liang F, Moret V, Wiesendanger M, Rouiller EM (1992). Mapping of the motor pathways in rats: c-fos induction by intracortical microstimulation of the motor cortex correlated with efferent connectivity of the site of cortical stimulation. Neuroscience 49: 749-761.
77. White FJ, Kalivas PW (1998). Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 51: 141-153.
78. Wise RA (1989). Opiate reward: sites and substrates. Neurosci Biobehav Rev 13: 129-133.